Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research – Anti Allergy Agents

Volume 5

eBook: US $49 Special Offer (PDF + Printed Copy): US $83
Printed Copy: US $59
Library License: US $196
ISSN: 2452-3194 (Print)
ISSN: 2214-6938 (Online)
ISBN: 978-981-5040-62-3 (Print)
ISBN: 978-981-5040-61-6 (Online)
Year of Publication: 2022
DOI: 10.2174/97898150406161220501

Introduction

Frontiers in Clinical Drug Research - Anti-Allergy Agents is a book series comprising of a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs.

The fifth volume of this series brings 5 reviews which cover the following topics:

- Resistin: an irresistible therapeutic target for inflammatory diseases, allergy-related disorders, and cancer

- Asthma in adults: evaluation, prevalence, and its clinical management

- Nitrogen-containing heterocycles as anti-allergy agents

- Experimental and clinical studies on the effects of nigella sativa and its constituents on allergic and immunological disorders

- Aspirin desensitization/challenge in patients with cardiovascular diseases: current trends and advances

Frontiers in Clinical Drug Research - Anti-Allergy Agents will be of interest to immunologists and drug discovery researchers interested in anti-allergic drug therapy as the series provides relevant cutting edge reviews written by experts in this rapidly expanding field.

Audience: Pharmaceutical scientists, immunologists and drug discovery researchers interested in anti-allergic drug therapy, clinicians and healthcare professionals in allergology.